Regarding ACS, in the PEACE trial, Serruys et al. showed that in patients with stable CAD elevated Lp-PLA2 and hs-CRP levels were significant predictors of acute coronary syndromes (P < 0.005 and 0.001, resp). This evidence concerns the gene PLA2G7 and coronary artery disorder.